oxybutynin has been researched along with sumatriptan in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 12 (92.31) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Freitag, F; Pearlman, SH; Rapoport, AM | 1 |
| Tfelt-Hansen, P | 1 |
| Goldstein, J; Pierce, MW; Pugach, N; Silberstein, S; Singer, R; Smith, TR | 1 |
| Goldstein, J; Griesser, J; Pierce, M; Pugach, N; Sebree, T; Smith, TR | 1 |
| Foster, S; Jennings, C; Meadows, KP; O'Neill, C; Pierce, M | 1 |
| Tepper, DE | 1 |
| Aschenbrenner, DS | 1 |
| Burch, RC; Loder, EW; Rayhill, M | 1 |
3 review(s) available for oxybutynin and sumatriptan
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Innovative delivery systems for migraine: the clinical utility of a transdermal patch for the acute treatment of migraine.
Topics: Clinical Trials as Topic; Drug Administration Routes; Female; Gastroparesis; Humans; Iontophoresis; Male; Migraine Disorders; Nausea; Serotonin 5-HT1 Receptor Agonists; Sumatriptan; Transdermal Patch; Treatment Outcome; Vomiting | 2010 |
Sumatriptan iontophoretic patch for migraine.
Topics: Humans; Iontophoresis; Migraine Disorders; Serotonin 5-HT1 Receptor Agonists; Sumatriptan; Transdermal Patch | 2014 |
2 trial(s) available for oxybutynin and sumatriptan
| Article | Year |
|---|---|
Twelve-month tolerability and efficacy study of NP101, the sumatriptan iontophoretic transdermal system.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Chemistry, Pharmaceutical; Female; Follow-Up Studies; Humans; Iontophoresis; Middle Aged; Migraine Disorders; Nausea; Pruritus; Sumatriptan; Time Factors; Transdermal Patch; Treatment Outcome; Young Adult | 2012 |
A sumatriptan iontophoretic transdermal system for the acute treatment of migraine.
Topics: Adult; Analgesics; Double-Blind Method; Female; Humans; Iontophoresis; Male; Migraine Disorders; Sumatriptan; Transdermal Patch; Treatment Outcome | 2012 |
8 other study(ies) available for oxybutynin and sumatriptan
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Low efficacy of transdermal sumatriptan in migraine.
Topics: Humans; Migraine Disorders; Randomized Controlled Trials as Topic; Sumatriptan; Transdermal Patch; Treatment Outcome | 2011 |
Sumatriptan transdermal system can be correctly assembled and applied during migraine attacks.
Topics: Adolescent; Adult; Drug Delivery Systems; Female; Follow-Up Studies; Humans; Iontophoresis; Male; Middle Aged; Migraine Disorders; Serotonin 5-HT1 Receptor Agonists; Sumatriptan; Transdermal Patch; Young Adult | 2014 |
A sumatriptan patch (Zecuity) for migraine.
Topics: Adult; Double-Blind Method; Humans; Migraine Disorders; Randomized Controlled Trials as Topic; Serotonin 5-HT1 Receptor Agonists; Sumatriptan; Transdermal Patch; United States; United States Food and Drug Administration | 2015 |
Sumatriptan Patch is Temporarily Suspended.
Topics: Administration, Cutaneous; Burns; Drug-Related Side Effects and Adverse Reactions; Humans; Migraine Disorders; Sumatriptan; Transdermal Patch | 2016 |
Safety Problems With a Transdermal Patch for Migraine: Lessons From the Development, Approval, and Marketing Process.
Topics: Adverse Drug Reaction Reporting Systems; Burns, Chemical; Cicatrix; Clinical Trials as Topic; Drug Approval; Drug Labeling; Humans; Iontophoresis; Marketing; Migraine Disorders; Multicenter Studies as Topic; Research Design; Social Media; Sumatriptan; Transdermal Patch; United States; Vasoconstrictor Agents | 2018 |